DAM
ACOR

DLD Asset Management’s Acorda Therapeutics ACOR Stock Holding History

DLD Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Hold
0
– – – 121
2020
Q2 		– Hold
0
– – – 109
2020
Q1 		– Hold
0
– – – 132
2019
Q1 		– Hold
0
– – – 131
2018
Q4 		– Hold
0
– – – 127
2018
Q3 		– Hold
0
– – – 146
2018
Q2 		– Hold
0
– – – 162
2018
Q1 		– Hold
0
– – – 139
2017
Q2 		– Sell
-2,349
Closed -$5.92M – 120
2017
Q1 		$5.92M Buy
2,349
+1,220
+108% +$3.51M 1.22% 19
2016
Q4 		$2.55M Buy
+1,129
New +$2.68M 1.11% 20

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $2.27B AUM 45.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return